Email this article to a friend
Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study
- † Equal contributors
BMC Cancer 2012, 12:547 doi:10.1186/1471-2407-12-547
